Literature DB >> 11500442

Production of matrix metalloproteinases in response to mycobacterial infection.

M Quiding-Järbrink1, D A Smith, G J Bancroft.   

Abstract

Matrix metalloproteinases (MMPs) constitute a large family of enzymes with specificity for the various proteins of the extracellular matrix which are implicated in tissue remodeling processes and chronic inflammatory conditions. To investigate the role of MMPs in immunity to mycobacterial infections, we incubated murine peritoneal macrophages with viable Mycobacterium bovis BCG or Mycobacterium tuberculosis H37Rv and assayed MMP activity in the supernatants by zymography. Resting macrophages secreted only small amounts of MMP-9 (gelatinase B), but secretion increased dramatically in a dose-dependent manner in response to either BCG or M. tuberculosis in vitro. Incubation with mycobacteria also induced increased MMP-2 (gelatinase A) activity. Neutralization of tumor necrosis alpha (TNF-alpha), and to a lesser extent interleukin 18 (IL-18), substantially reduced MMP production in response to mycobacteria. Exogenous addition of TNF-alpha or IL-18 induced macrophages to express MMPs, even in the absence of bacteria. The immunoregulatory cytokines gamma interferon (IFN-gamma), IL-4, and IL-10 all suppressed BCG-induced MMP production, but through different mechanisms. IFN-gamma treatment increased macrophage secretion of TNF-alpha but still reduced their MMP activity. Conversely, IL-4 and IL-10 seemed to act by reducing the amount of TNF-alpha available to the macrophages. Finally, infection of BALB/c or severe combined immunodeficiency (SCID) mice with either BCG or M. tuberculosis induced substantial increases in MMP-9 activity in infected tissues. In conclusion, we show that mycobacterial infection induces MMP-9 activity both in vitro and in vivo and that this is regulated by TNF-alpha, IL-18, and IFN-gamma. These findings indicate a possible contribution of MMPs to tissue remodeling processes that occur in mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500442      PMCID: PMC98682          DOI: 10.1128/IAI.69.9.5661-5670.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  Cytokine/chemokine cascades in immunity to tuberculosis.

Authors:  I M Orme; A M Cooper
Journal:  Immunol Today       Date:  1999-07

2.  IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection.

Authors:  V E García; K Uyemura; P A Sieling; M T Ochoa; C T Morita; H Okamura; M Kurimoto; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

3.  Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.

Authors:  S L Leib; D Leppert; J Clements; M G Täuber
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1.

Authors:  T K Held; X Weihua; L Yuan; D V Kalvakolanu; A S Cross
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 5.  Matrix metalloproteinase degradation of extracellular matrix: biological consequences.

Authors:  S D Shapiro
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

6.  Murine microglial cells produce and respond to interleukin-18.

Authors:  M Prinz; U K Hanisch
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

7.  Macrophages are a significant source of type 1 cytokines during mycobacterial infection.

Authors:  J Wang; J Wakeham; R Harkness; Z Xing
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

8.  Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis.

Authors:  A Kirchner; U Koedel; V Fingerle; R Paul; B Wilske; H W Pfister
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

9.  Involvement of matrix metalloproteinases in human immunodeficiency virus type 1-induced replication by clinical Mycobacterium avium isolates.

Authors:  C S Dezzutti; W E Swords; P C Guenthner; D R Sasso; L M Wahl; A H Drummond; G W Newman; C H King; F D Quinn; R B Lal
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

10.  Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system.

Authors:  L Tsenova; A Bergtold; V H Freedman; R A Young; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  35 in total

1.  MMPs in tuberculosis: granuloma creators and tissue destroyers.

Authors:  Padmini Salgame
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

Review 2.  The paradox of matrix metalloproteinases in infectious disease.

Authors:  P T G Elkington; C M O'Kane; J S Friedland
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 3.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 4.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

5.  The In Vitro and In Vivo Response to MMP-Sensitive Poly(Ethylene Glycol) Hydrogels.

Authors:  Luke D Amer; Stephanie J Bryant
Journal:  Ann Biomed Eng       Date:  2016-04-14       Impact factor: 3.934

6.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Jerome B Zeldis; George Muller; Gilla Kaplan
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

7.  Interleukin-18, matrix metalloproteinase-22 and -29 are independent risk factors of human coronary heart disease.

Authors:  Dong-Yi Jin; Cong-Lin Liu; Jun-Nan Tang; Zhao-Zhong Zhu; Xue-Xi Xuan; Xiao-Dan Zhu; Yun-Zhe Wang; Tian-Xia Zhang; De-Liang Shen; Xiao-Fang Wang; Guo-Ping Shi; Jin-Ying Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2017 Aug.       Impact factor: 3.066

8.  Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

Authors:  Ying-De Wang; Jing-Wei Mao
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.

Authors:  Rosane M B Teles; Rose B Teles; Thais P Amadeu; Danielle F Moura; Leila Mendonça-Lima; Helen Ferreira; Italo M C F Santos; José A C Nery; Euzenir N Sarno; Elizabeth P Sampaio
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

10.  Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

Authors:  Y Luo; H Yamada; X Chen; A A Ryan; D P Evanoff; J A Triccas; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.